Detection of Viral RNA in Tissues following Plasma Clearance from an Ebola Virus Infected Patient

18Citations
Citations of this article
57Readers
Mendeley users who have this article in their library.

Abstract

An unprecedented Ebola virus (EBOV) epidemic occurred in 2013–2016 in West Africa. Over this time the epidemic exponentially grew and moved to Europe and North America, with several imported cases and many Health Care Workers (HCW) infected. Better understanding of EBOV infection patterns in different body compartments is mandatory to develop new countermeasures, as well as to fully comprehend the pathways of human-to-human transmission. We have longitudinally explored the persistence of EBOV-specific negative sense genomic RNA (neg-RNA) and the presence of positive sense RNA (pos-RNA), including both replication intermediate (antigenomic-RNA) and messenger RNA (mRNA) molecules, in the upper and lower respiratory tract, as compared to plasma, in a HCW infected with EBOV in Sierra Leone, who was hospitalized in the high isolation facility of the National Institute for Infectious Diseases “Lazzaro Spallanzani” (INMI), Rome, Italy. We observed persistence of pos-RNA and neg-RNAs in longitudinally collected specimens of the lower respiratory tract, even after viral clearance from plasma, suggesting possible local replication. The purpose of the present study is to enhance the knowledge on the biological features of EBOV that can contribute to the human-to-human transmissibility and to develop effective intervention strategies. However, further investigation is needed in order to better understand the clinical meaning of viral replication and shedding in the respiratory tract.

Figures

  • Fig 1. EBOV RNA trends in plasma, sputum and nasopharyngeal specimens during the first 15 days of hospitalization of the second Italian Ebola patient attending the National Institute for Infectious Diseases in Roma (INMI2). Clinical specimens from the patient were collected daily (plasma and nasopharyngeal swab) and regularly throughout hospitalization (Sputum). Arrows indicate the administration of the experimental drug Mil77 (day 3 and day 6). Dotted lines represent the hypothetical trend of those samples not available for this study. Panel A: trend of total EBOV RNA (viremia), which becomes undetectable at day 9. Panel B: trends of neg-RNA and pos-RNA in plasma, which become undetectable at day 5 and 4, respectively. Panel C: trend of total virus RNA in sputum, which becomes undetectable at day 11. Panel D: trends of neg-RNA and pos-RNA in sputum, which become undetectable at day 11 and 10, respectively. Panel E: trend of total EBOV RNA in nasopharyngeal swab. In nasopharyngeal swab the total EBOV RNA reaches undetectable levels at day 13 of hospitalization. Panel F: trends of neg-RNA and pos-RNA in nasopharyngeal swab, which become undetectable at day 10 and 6, respectively. Symbols are specified in the panels.

References Powered by Scopus

This article is free to access.

This article is free to access.

This article is free to access.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Biava, M., Caglioti, C., Bordi, L., Castilletti, C., Colavita, F., Quartu, S., … Lalle, E. (2017). Detection of Viral RNA in Tissues following Plasma Clearance from an Ebola Virus Infected Patient. PLoS Pathogens, 13(1). https://doi.org/10.1371/journal.ppat.1006065

Readers over time

‘17‘18‘19‘20‘21‘22‘23‘2405101520

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 16

55%

Researcher 10

34%

Professor / Associate Prof. 3

10%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 9

32%

Medicine and Dentistry 9

32%

Nursing and Health Professions 5

18%

Biochemistry, Genetics and Molecular Bi... 5

18%

Article Metrics

Tooltip
Mentions
Blog Mentions: 1
News Mentions: 9
Social Media
Shares, Likes & Comments: 19

Save time finding and organizing research with Mendeley

Sign up for free
0